Glycobiology Advance Access published online on December 23, 2003
Glycobiology, doi:10.1093/glycob/cwh039
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2003 Oxford University Press
ORIGINAL ARTICLES
1 Glycobiology Research and Training Center, Departments of Medicine and Cellular & Molecular Medicine, University of California, San Diego, La Jolla, California 92093-0687, USA Most mammalian cell surfaces display two major sialic acids (Sias), N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc). Humans lack Neu5Gc due to a mutation in CMP-Neu5Ac hydroxylase, which occurred after our evolutionary divergence from great apes. Here we describe an apparent consequence of human Neu5Gc loss: domain-specific functional adaptation of Siglec-9, a member of the family of sialic acid-binding receptors of innate immune cells designated the CD33-related Siglecs (CD33rSiglecs). Binding studies on recombinant human Siglec-9 show recognition of both Neu5Ac and Neu5Gc. In striking contrast, chimpanzee and gorilla Siglec-9 strongly prefer binding Neu5Gc. Simultaneous probing of multiple endogenous CD33rSiglecs on circulating blood cells of human, chimpanzee, or gorilla suggests that the binding differences observed for Siglec-9 are representative of multiple CD33rSiglecs. We conclude that Neu5Ac-binding ability of at least some human CD33rSiglecs is a derived state, which was selected for following loss of Neu5Gc in the hominid lineage. These data also indicate that endogenous Sias (rather than surface Sias of bacterial pathogens) are the functional ligands of CD33rSiglecs, and suggest that the endogenous Sia landscape is the major factor directing evolution of CD33rSiglec binding specificity. Exon-1-encoded Sia-recognizing domains of human and ape Siglec-9 share only
Revised on November 19, 2003
Accepted on November 24, 2003
A uniquely human consequence of domain-specific functional adaptation in a sialic acid-binding receptor
93-95% amino acid identity. In contrast, the immediately adjacent intron and exon-2 have the
98-100% identity typically observed amongst these species. Taken together, our findings suggest ongoing adaptive evolution specific to the Sia-binding domain, possibly of an episodic nature. Such domain-specific divergences should also be considered in upcoming comparisons of human and chimpanzee genomes.
sialic acid, Siglec, human evolution, domain-specific adaptation, comparative biology
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Angata, T. Hayakawa, M. Yamanaka, A. Varki, and M. Nakamura Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates FASEB J, October 1, 2006; 20(12): 1964 - 1973. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Avril, S. J. North, S. M. Haslam, H. J. Willison, and P. R. Crocker Probing the cis interactions of the inhibitory receptor Siglec-7 with {alpha}2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of {alpha}2,8-sialyltransferase gene expression J. Leukoc. Biol., October 1, 2006; 80(4): 787 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Altheide, T. Hayakawa, T. S. Mikkelsen, S. Diaz, N. Varki, and A. Varki System-wide Genomic and Biochemical Comparisons of Sialic Acid Biology Among Primates and Rodents: EVIDENCE FOR TWO MODES OF RAPID EVOLUTION J. Biol. Chem., September 1, 2006; 281(35): 25689 - 25702. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Nguyen, N. Hurtado-Ziola, P. Gagneux, and A. Varki Loss of Siglec expression on T lymphocytes during human evolution PNAS, May 16, 2006; 103(20): 7765 - 7770. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Shiu, J. K. Byrnes, R. Pan, P. Zhang, and W.-H. Li Role of positive selection in the retention of duplicate genes in mammalian genomes PNAS, February 14, 2006; 103(7): 2232 - 2236. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Varki and T. Angata Siglecs--the major subfamily of I-type lectins Glycobiology, January 1, 2006; 16(1): 1R - 27R. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Varki and T. K. Altheide Comparing the human and chimpanzee genomes: Searching for needles in a haystack Genome Res., December 1, 2005; 15(12): 1746 - 1758. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bardor, D. H. Nguyen, S. Diaz, and A. Varki Mechanism of Uptake and Incorporation of the Non-human Sialic Acid N-Glycolylneuraminic Acid into Human Cells J. Biol. Chem., February 11, 2005; 280(6): 4228 - 4237. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hurtado-Ziola, J. L. Sonnenburg, and A. Varki Differential Expression and Function of the CD33-Related Siglecs between Humans and Great Apes. Blood (ASH Annual Meeting Abstracts), November 16, 2004; 104(11): 1466 - 1466. [Abstract] |
||||
![]() |
E. J. Vallender and B. T. Lahn Positive selection on the human genome Hum. Mol. Genet., October 1, 2004; 13(suppl_2): R245 - R254. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Angata, E. H. Margulies, E. D. Green, and A. Varki Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms PNAS, September 7, 2004; 101(36): 13251 - 13256. [Abstract] [Full Text] [PDF] |
||||







